Evolve IP®, The Cloud Strategy Company™, today announced that it was awarded the M&A Deal of the Year at the ICT Investment Forum for its 2018 acquisition of thevoicefactory (TVF). Since the...

PRA Group (Nasdaq: PRAA), a global leader in acquiring and collecting nonperforming loans, will present to investors attending the Raymond James 40th Annual Institutional Investors Conference on...

Johnson & Johnson Consumer Inc. will present a diverse portfolio of scientific research across skin and hair physiology at this year's American Academy of Dermatology (AAD) Annual Meeting in...

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Barclays Global Healthcare Conference on Wednesday, March 13, 2019. Michael Severino, vice chairman...

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced that...

Allergan plc (NYSE: AGN) today announced that its data will be featured during the 2019 American Academy of Dermatology (AAD) Annual Meeting in Washington D.C. March 1-5, 2019. The meeting will be...

Endo To Present Data From Two Abstracts on Collagenase Clostridium Histolyticum DUBLIN, March 1, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it will present new...

Rodan & Fields, LLC (Rodan + Fields), a prestige, dermatology-inspired skincare brand, and the #1 skincare brand in North America in 2017,1 will present four Scientific Posters at this year's...

- Late breaking presentation of the Phase 2b long-term findings on the investigational molecule, bimekizumab, demonstrates complete or almost complete skin clearance in moderate-to-severe plaque...

Late breaking presentation of the Phase 2b long-term findings on the investigational molecule, bimekizumab, demonstrates complete or almost complete skin clearance in moderate-to-severe plaque...